Abstract
Structural and functional impairment of podocytes plays an important role in the development of diabetic nephropathy, a chronic complication of diabetes mellitus and leading cause of renal failure requiring renal replacement therapy. Autophagy plays a crucial role in podocyte viability and function, and its activity is modulated by a variety of pathophysiological factors found in diabetic milieu. Here we show that downregulation of autophagy is critical for podocyte survival in hyperglycemic environment. Moreover, long-term exposure to high glucose leads to inhibition of autophagy as well as to the development of insulin resistance in podocytes. Furthermore, impairment of autophagy is involved in alteration of insulin-dependent glucose uptake in podocytes, suggesting a relationship between these two processes. Taken together, our findings suggest that downregulation of podocyte autophagy, observed after long-term exposure to high glucose, results from their suppressed sensitivity to insulin, and may therefore lead to diminished podocyte cell viability as well as their reduced number in glomerulus.
Introduction
Podocytes play a key role in the regulation of glomerular permeability to albumin and maintain spatial structure of glomerulus by withstanding high intraglomerular hydrostatic pressure, mainly through a well-developed contractile apparatus formed by actin and myosin filament bundles [1]. These terminally differentiated epithelial cells are situated on the urinary side of glomerular capillaries and together with the glomerular basement membrane (GBM) and endothelial cells form renal filtration barrier. They are anchored to the GBM through their foot processes, and adjacent foot processes interdigitate, creating a narrow space (30–50 nm) with a complex set of membrane proteins, called glomerular slit diaphragm [2]. Within the renal filtration barrier podocytes are the cells that are uniquely insulin-sensitive and capable of increasing extracellular glucose uptake in response to insulin stimulation by facilitating glucose transporter translocation to cell membranes [3]. Altered morphology and reduced number of podocytes are the earliest pathological manifestations associated with diabetic nephropathy (DN), a leading cause of renal failure requiring renal replacement therapy in diabetic patients [4, 5]. Progressive development of insulin resistance observed at the early stage of type 2 diabetes causes an increase in blood glucose concentration (hyperglycemia) and compensatory rise of insulin levels [5]. Insulin resistance is characterized by a suppressed insulin-stimulated glucose uptake by the cells, resulting from the impairment of intracellular insulin signaling pathways and disability to increase the amount of glucose transporters (GLUTs) in the cell membrane [6]. Defective insulin responsiveness occurs as a consequence of genetic susceptibility and effects of extracellular agents [7], among which the excess of free fatty acids, chronic hyperglycemia and hyperinsulinemia are currently of particular research interest [8, 9].
Long-term hyperglycemia causes impairment of podocytes morphology and function, including foot processes effacement, hypertrophy, detachment from the GBM, and apoptosis, thus leading to the increased permeability of the filtration barrier to albumin and progressive decline of renal function [10]. Podocytes have very limited ability for cell division, therefore, their loss, although initially balanced by hypertrophy of the remaining podocytes, cannot be compensated by proliferation or efficient recruitment and differentiation of other glomerular cells [11, 12]. To endure adverse environmental changes, podocytes activate their intracellular defense mechanisms, among which autophagy is thought to be the most important one [13].
Autophagy serves as an adaptive mechanism aimed to remove improperly folded proteins and non-functional intracellular organelles, which might be produced during enhanced protein synthesis observed in cellular hypertrophy. Autophagic process involves a series of following steps including initiation, cargo recognition, autophagosome formation, autophagosome-lysosome fusion, digestion, and release of digested products into the cytoplasm. The process is initiated by Unc-51-like kinase-1/2 (ULK1/2) complex, under control of AMP-activated and the mammalian target of rapamycin (mTOR) kinases [14]. The membrane of the autophagosome is doubled in elongation process and its closure is regulated by Beclin1/PI3K class III complex, together with two conjugating systems involving LC3 protein processing and Atg12-Atg5-Atg16 complex [15]. Activity of autophagy is closely related to intracellular energy state, and all its signaling pathways are tightly regulated. Starvation, increased reactive oxygen species generation, or mechanical stress are the strong inducers of autophagy, aimed to maintain intracellular homeostasis in harsh conditions [16, 17].
Although the pathogenesis of DN remains to be fully elucidated, autophagy is currently considered as one of the key factors contributing to the disease [18–20]. Impaired autophagic activity in podocytes was observed in diabetic patients with proteinuria but not in those with no or minimal proteinuria [19]. It was also demonstrated on mice that podocyte-specific Atg5 deletion and high-fat diet lead to albuminuria, activation of apoptosis in podocytes and their loss [19]. Moreover, inhibition of podocytes autophagy in mice (Atg5 knockout) resulted in albuminuria by 2 months of age, renal segmental lesions with hyalinosis, and tuft-to-capsule adhesions by 4 months of age [21], indicating that proper podocyte autophagy is critical for normal kidney function. Additionally, recently published studies suggest that autophagy may be directly linked to the development of podocyte insulin resistance [22] and may constitute a protective mechanism against high glucose-dependent development of insulin resistance in these cells [23]; therefore, it is of interest to further investigate the significance of autophagy for viability and insulin responsiveness of primary rat podocytes exposed to high concentration of glucose or insulin.
Materials and methods
Reagents
Cell culture reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA), with the exception of fetal bovine serum (FBS), which was purchased from Gibco, Invitrogen (Carlsbad, CA, USA). Rabbit polyclonal antibodies against LC3 and mouse monoclonal antibody against actin were obtained from Sigma-Aldrich. Alkaline phosphatase-conjugated secondary antibodies (goat anti-rabbit and donkey anti-mouse antibodies) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Small interfering RNA (siRNA) targeting Atg5 and its non-silencing control siRNA were obtained from OriGene (Rockville, MD, USA). Plasmid ptfLC3 was purchased from Addgene (plasmid 21,074). [1,2-3H]-deoxy-d-glucose was obtained from MP Biochemicals (Santa Ana, CA, USA). All other reagents were purchased from Sigma-Aldrich.
Primary podocyte culture
All rats were maintained and studied in accordance with the protocol reviewed and approved by the local Bioethical Committee at the Medical University of Gdansk (No. 4/2012). Primary rat podocytes were obtained from Wistar female rats weighing 100–120 g as described previously [24]. Cell phenotypes were determined using podocyte-specific antibodies against Wilms’ tumor-1 protein (WT-1; Biotrend Koeln, Germany) and synaptopodin (Progen, Heidelberg, Germany). Depending on the experiment, podocytes were incubated in high glucose medium (HG; 30 mM d-glucose), osmotic control medium (Osm con; 11 mM d-glucose with 19 mM l-glucose), or standard glucose medium (SG; 11 mM d-glucose).
Western blot analysis
Podocytes were washed with ice-cold PBS and homogenized in an ice-cold lysis buffer. The lysates were then centrifuged for 20 min at 15,000×g. Equal amounts of protein extracts (20 μg per well) were resolved by SDS-PAGE, transferred onto a PVDF membrane, and blocked with 3% fat-free milk in TBS (20 mM Tris-HCl, 140 mM NaCl). Next, the membrane was incubated overnight with primary antibodies against LC3 (1:500) and actin (1:3000). Following incubation with the appropriate secondary alkaline phosphatase-conjugated antibodies (1:5000), protein bands were detected using the colorimetric 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT) system. Densitometric quantification of bands was performed with Quantity One software (Bio-Rad, Hercules, CA, USA).
Nucleofection with plasmid DNA
Podocytes seeded on type I collagen-coated 24-well plates (Greiner Bio-One, Austria) at 70–80% confluency were transfected with an Amaxa AD1 Primary Cell 4D-Nucleofector-Y Kit (Lonza, Switzerland) and ptfLC3 plasmid (16 µg per well) using the FB-166 program on the 4D-Nucleofector System (Lonza). Immediately after nucleofection, cells were transferred into 1 ml of pre-warmed RPMI 1640 medium.
Cell were incubated in indicated media, and every 24-h 15–30, images were taken using an Olympus IX51 fluorescence microscope (Olympus, Japan). Total fluorescence signal was measured for autophagosomes and autolysosomes using CellSens Dimension software (Olympus, Japan). The results were presented as autolysosome to autophagosome fluorescence ratios.
siRNA transfection
Podocytes were cultured in type I collagen-coated culture flasks in RPMI 1640 with 10% FBS and then transfected with siRNA Transfection Reagent (Santa Cruz Biotechnology) following the manufacturer’s instructions. Non-specific (scrambled) siRNA and Atg5 siRNA were diluted in Transfection Medium to a final concentration of 50 nM. Cells were cultured for 24 h and then incubated in SG, HG, or Osm con medium for 5 days. Parallel to monitoring autophagic vacuoles formation in Atg5 siRNA transfected viable podocytes, nucleofection using ptfLC3 was performed.
MTT test
Podocytes were seeded at 3 × 104/well on a type I collagen-coated 24-well plate, and cultured under control and experimental conditions. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added to each well to a final concentration of 0.2 mg/ml. Next cells were incubated at 37 °C for 4 h, medium was removed, and the intracellular formazan was solubilized in 300 μl DMSO. Absorbance was measured at 560 nm with a reference of 690 nm using a VICTOR3 Multilabel Counter 1420 (Perkin Elmer, Waltham, USA).
[1,2-3H]-deoxy-d-glucose (2-DG) uptake measurements
Podocytes were cultured on a type I collagen-coated 24-well plate under control (SG) and experimental (SG supplemented with 300 nM insulin) conditions. On the day of experiment, cells were starved for 2 h in FBS- and glucose-free medium. Next [1,2-3H]-deoxy-d-glucose (2-DG) was added to a final concentration of 1 μCi/well and podocytes were incubated in 37 °C, 5% CO2 for 3 min. 400 μl of medium from each well was suspended in 2 ml of scintillator cocktail for extracellular radioactivity measurements by liquid scintillation counting (MicroBeta2®, Perkin Elmer, Waltham, USA). Remaining medium was removed, podocytes were washed three times with ice-cold PBS and lysed in 0.05 N NaOH for 1.5 h at room temperature. The lysates (400 μl/well) were transferred to scintillator cocktail (2 ml) and intracellular radioactivity was measured (MicroBeta2®, Perkin Elmer, Waltham, USA). The remaining lysates (100 μl) were used to determine the protein concentration using Bradford method [25].
Statistics
All data are expressed as mean ± SEM. Quantitative comparisons were performed using ANOVA followed by the Student–Newman–Keuls multiple comparison test. A P value of <0.05 was considered significant.
Results
Autophagy is involved in extracellular high glucose concentration-dependent decrease in primary rat podocyte viability
In order to determine the viability of primary rat podocytes cultured in HG medium, MTT test was conducted. After 5 days of incubation in HG, we observed a reduction of metabolically active podocytes of about 22% in HG medium (30 mM d-glucose) when compared to SG medium (11 mM d-glucose) (P < 0.05), while in podocytes cultured for 5 days in SG and subsequent staurosporine stimulation (0.5 μM, 3 h; positive control), there was 30% decrease in cell viability (P < 0.05) (Fig. 1a).
Next, we investigated whether autophagy is involved in the reduced podocyte viability in HG. Incubation of Atg5-depleted podocytes in HG medium for 5 days led to the decline in cell viability of about 42% (P < 0.05) when compared to podocytes maintained in SG medium (Fig. 1b). Podocytes transfected with non-targeting siRNA (negative control) and cultured in HG for 5 days had abolished cell viability by 24% (P < 0.05) (Fig. 1b). To exclude the effect of elevated osmotic pressure in HG medium on podocytes, we assessed podocyte viability in non-transfected and transfected cells cultured for 5 days in high osmolarity (11 mM d-glucose with 19 mM l-glucose; Osm con) and SG medium (Fig. 1a, b). Autophagy downregulation in podocytes resulted in approximately 2,5-fold decrease in autolysosome/autophagosome ratio 5 days after the transfection (Fig. 1c).Transfection conditions did not affect podocytes viability (Fig. 1d). Podocyte transfection with Atg5 siRNA resulted in the decrease of Atg5–Atg12 complex formation by 30% (Fig. 1e).
High glucose impairs activity of autophagy in primary rat podocytes
Autophagy flux was analyzed in primary rat podocytes transfected by nucleofection with ptfLC3 plasmid expressing RFP-GFP-LC3 construct, which enables tracing autophagosome and autolysosome formation in viable cells within the course of time. After 5 days of podocyte incubation in HG medium, we observed significant decrease in LC3-II protein expression of about 32% when compared to SG medium (0.37 ± 0.04 vs. 0.25 ± 0.05, P < 0.05) (Fig. 2a, b). The LC3-I level was unchanged in podocytes cultured in both SG and HG (Fig. 2a, b). Reduced number of autolysosomes (red dots) toward autophagosomes (yellow/green dots) was observed in the fluorescence images of podocytes cultured for 5 days in HG medium (Fig. 2c), what was confirmed in the autophagy flux analyses (Fig. 2d).
Downregulation of autophagy alleviates podocyte responsiveness to insulin
In order to determine if autophagy plays an important role in podocyte sensitivity to insulin, we transfected podocytes with Atg5 siRNA or non-specific control siRNA and analyzed time-dependent effects of insulin (300 nM) on intracellular [1,2-3H]-deoxy-d-glucose (2-DG) uptake. The uptake of 2-DG in podocytes transfected with control siRNA was increased by 35% after 60 min of insulin stimulation (5.38 ± 0.64 nmol/min/mg protein vs. 7.27 ± 1.23 nmol/min/mg protein, P < 0.05) (Fig. 3a), whereas 3 as well as 5 days of stimulation with insulin abolished this effect (control: 5.38 ± 0.64 nmol/min/mg protein; 3-days insulin incubation: 5.4 ± 1.03 nmol/min/mg; 5-days insulin incubation: 4.52 ± 0.98 nmol/min/mg protein) (Fig. 3a). However, in Atg5-depleted podocytes, we did not observe any effect of insulin on intracellular 2-DG transport at any of the time points (Fig. 3a).
To determine the involvement of Atg5 in sensitivity of primary rat podocytes to insulin, we analyzed insulin-dependent uptake of 2-DG into the podocytes transfected with Atg5 siRNA or non-targeting siRNA after subsequent incubation in SG, HG, and Osm con media for 5 days. In podocytes transfected with non-specific siRNA and cultured in SG or Osm con, short stimulation with insulin (300 nM, 3 min) resulted in significantly increased 2-DG transport into the cells by about 28 and 29%, respectively (2.34 ± 0.22 nmol/min/mg protein vs. 2.99 ± 0.15 nmol/min/mg protein (SG) and 2.47 ± 0.23 nmol/min/mg protein vs. 3.2 ± 0.26 nmol/min/mg protein (Osm con), P < 0.05), while there was no effect of insulin on 2-DG uptake into podocytes cultured for 5 days in HG medium (Fig. 3b). Similar effect was observed in podocytes with downregulated autophagy, where stimulation with insulin (300 nM, 3 min) caused significant increase in 2-DG transport after incubation in SG medium (Δ32%, P < 0.05) or Osm con medium (Δ37%, P < 0.05) for 5 days, whereas there was no effect of insulin on 2-DG uptake in podocytes cultures in HG medium (Fig. 3c).
Discussion
Autophagy constitutes one of the most important defense mechanisms involved in maintaining podocytes intracellular homeostasis by removing misfolded proteins and non-functional organelles [20, 26]. Basal activity of podocytes autophagy, the highest among all the kidney cells [13], is associated with high metabolic activity of these non-dividing cells to sustain permanent filtration of large volume of serum (600 ml/min in human) and low-molecular-weight proteins, including albumin (up to several g/day), and result in the necessity of constant intracellular proteomic turnover. DN is characterized by the impairment of renal filtration mainly due to alterations in podocyte morphology and function, therefore multiple studies have been trying to elucidate the potential effects of diabetic milieu on podocyte physiology. Previously published reports do not provide unequivocal answer whether autophagy is activated or inhibited in high glucose environment (HG). It has been shown that number of autophagosomes in podocytes in diabetic rats is increased. Moreover, increased LC3 and beclin1 expression was shown in immortalized mice podocytes cultured in HG [27]. In contrary, it has also been shown that both markers of autophagy as well as number of autophagic vacuoles were decreased in different models of experimental diabetes [28]. Recent study has shown a decrease in the LC3-II expression and in the number of autophagic vesicles in podocytes of diabetic patients and rodents. Moreover, decreased podocyte viability has been observed in HG [19]. In our work, we have shown that long-term exposure of primary rat podocytes to high glucose indeed promotes podocyte death, and attenuation of autophagy further deteriorates this process. Experimental conditions, which were used to inhibit podocyte autophagy, did not affect cell viability in control environment, therefore indicating that podocytes are capable to compensate mild disturbances in autophagy activity, however, not under long-term exposure to unfavorable milieu. Additionally, we observed a reduced expression of LC3-II and a decreased number of intracellular autophagic vacuoles in podocytes cultured for 5 days in HG, when compared with both standard medium and osmotic control. Thus, there was no effect of the osmotic pressure on the autophagy activity in cells cultured in HG. In our previous work, we have shown that podocytes cultured for 5 days in HG failed to increase d-glucose uptake in response to insulin treatment [29]. Moreover, variety of cell types has been reported to develop insulin resistance following the long-term insulin treatment [9, 30, 31]. In the current work, we have shown for the first time that mild inhibition of autophagy activity is sufficient to impair responsiveness of podocytes to insulin that was observed in cells transfected with Atg5 siRNA. 2-DG uptake was unchanged after 60 min of insulin treatment, whereas in control podocytes, intracellular 2-DG transport was increased by 35%. After long-term incubation with insulin (3 and 5 days), there was no effect of insulin on 2-DG uptake in podocytes transfected with Atg5 or scrambled siRNA, what may indicate the development of insulin resistance in podocytes. These results are in agreement with recently published work of Xu et al., where the authors observed decreased autophagy in immortalized human podocytes after knocking down the insulin receptor, suggesting that proper insulin signaling is critical for autophagy in podocytes [22]. We have also shown direct influence of insulin on the expression of markers of autophagy in podocytes, as well as on their permeability to albumin [24]. In our present study, we have also investigated if downregulation of autophagy has any effect on the 2-DG uptake in podocytes cultured in HG. Here, in both transfected with Atg5 or scrambled siRNA cell cultures, we observed abolished effect of HG on insulin-dependent intracellular 2-DG transport, indicating that preceding downregulation of Atg5 signaling, which may impair autophagy activity, does not influence insulin resistance development after long-term HG treatment. However, it should be noted that high percentage of podocytes dying in HG may also indicate a progressive deterioration of remaining cell function and viability, which might involve a dysregulation of various intracellular pathways, including insulin signaling pathway. Therefore, this aspect can be a promising field for further investigation.
Taking under account all studies conducted so far, it seems possible, that downregulation of autophagy, that is observed in podocytes exposed to hyperglycemic environment, can represent the effect of reduced sensitivity of podocytes to insulin elicited by long-term exposure to HG, and may also contribute to the decreased viability of these cells.
References
Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83:253–307. doi:10.1152/physrev.00020.2002
Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17:428–437. doi:10.1016/j.tcb.2007.06.006
Coward RJ, Welsh GI, Yang J, Tasman C, Lennon R, Koziell A, Satchell S, Holman GD, Kerjaschki D, Tavare JM, Mathieson PW, Saleem MA (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102
Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99:342–348. doi:10.1172/jci119163
Jauregui A, Mintz DH, Mundel P, Fornoni A (2009) Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria. Curr Opin Nephrol Hypertens 18:539–545
Lay A, Coward RJ (2014) Recent advances in our understanding of insulin signalling to the podocyte. Nephrol Dial Transplant 29:1127–1133. doi:10.1093/ndt/gft471
DeFronzo RA (2004) Pathogenesis of type 2 diabetes mellitus. Med Clin N Am 88(787–835):ix. doi:10.1016/j.mcna.2004.04.013
Hafizi Abu Bakar M, Kian Kai C, Wan Hassan WN, Sarmidi MR, Yaakob H, Zaman Huri H (2015) Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids. Diabetes Metab Res Rev 31:453–475. doi:10.1002/dmrr.2601
Liu HY, Cao SY, Hong T, Han J, Liu Z, Cao W (2009) Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM). J Biol Chem 284:27090–27100
Ziyadeh FN, Wolf G (2008) Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4:39–45
Marshall CB, Shankland SJ (2006) Cell cycle and glomerular disease: a minireview. Nephron Exp Nephrol 102:e39–e48
Wiggins JE, Goyal M, Sanden SK, Wharram BL, Shedden KA, Misek DE, Kuick RD, Wiggins RC (2005) Podocyte hypertrophy, “adaptation,” and “decompensation” associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction. J Am Soc Nephrol 16:2953–2966. doi:10.1681/asn.2005050488
Hartleben B, Godel M, Meyer-Schwesinger C, Liu S, Ulrich T, Kobler S, Wiech T, Grahammer F, Arnold SJ, Lindenmeyer MT, Cohen CD, Pavenstadt H, Kerjaschki D, Mizushima N, Shaw AS, Walz G, Huber TB (2010) Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 120:1084–1096. doi:10.1172/jci39492
Shang L, Chen S, Du F, Li S, Zhao L, Wang X (2011) Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci 108:4788–4793. doi:10.1073/pnas.1100844108
Tanida I (2011) Autophagy basics. Microbiol Immunol 55:1–11. doi:10.1111/j.1348-0421.2010.00271.x
He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93. doi:10.1146/annurev-genet-102808-114910
King JS, Veltman DM, Insall RH (2011) The induction of autophagy by mechanical stress. Autophagy 7:1490–1499
Yamahara K, Yasuda M, Kume S, Koya D, Maegawa H, Uzu T (2013) The role of autophagy in the pathogenesis of diabetic nephropathy. J Diabetes Res 2013:193757. doi:10.1155/2013/193757
Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65:755–767. doi:10.2337/db15-0473
Yasuda-Yamahara M, Kume S, Tagawa A, Maegawa H, Uzu T (2015) Emerging role of podocyte autophagy in the progression of diabetic nephropathy. Autophagy 11:2385–2386. doi:10.1080/15548627.2015.1115173
Kawakami T, Gomez IG, Ren S, Hudkins K, Roach A, Alpers CE, Shankland SJ, D’Agati VD, Duffield JS (2015) Deficient autophagy results in mitochondrial dysfunction and FSGS. J Am Soc Nephrol 26:1040–1052. doi:10.1681/asn.2013111202
Xu Y, Zhou Q, Xin W, Li Z, Chen L, Wan Q (2016) Autophagy downregulation contributes to insulin resistance mediated injury in insulin receptor knockout podocytes in vitro. PeerJ 4:e1888. doi:10.7717/peerj.1888
Xin W, Li Z, Xu Y, Yu Y, Zhou Q, Chen L, Wan Q (2016) Autophagy protects human podocytes from high glucose-induced injury by preventing insulin resistance. Metabolism 65:1307–1315. doi:10.1016/j.metabol.2016.05.015
Audzeyenka I, Rogacka D, Piwkowska A, Rychlowski M, Bierla JB, Czarnowska E, Angielski S, Jankowski M (2016) Reactive oxygen species are involved in insulin-dependent regulation of autophagy in primary rat podocytes. Int J Biochem Cell Biol 75:23–33. doi:10.1016/j.biocel.2016.03.015
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Kume S, Koya D (2015) Autophagy: a novel therapeutic target for diabetic nephropathy. Diabetes Metab J 39:451–460. doi:10.4093/dmj.2015.39.6.451
Ma T, Zhu J, Chen X, Zha D, Singhal PC, Ding G (2013) High glucose induces autophagy in podocytes. Exp Cell Res 319:779–789. doi:10.1016/j.yexcr.2013.01.018
Fang L, Zhou Y, Cao H, Wen P, Jiang L, He W, Dai C, Yang J (2013) Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury. PLoS One 8:e60546. doi:10.1371/journal.pone.0060546
Jankowski M, Piwkowska A, Rogacka D, Audzeyenka I, Janaszak-Jasiecka A, Angielski S (2011) Expression of membrane-bound NPP-type ecto-phosphodiesterases in rat podocytes cultured at normal and high glucose concentrations. Biochem Biophys Res Commun 416:64–69. doi:10.1016/j.bbrc.2011.10.144
Gonzalez E, Flier E, Molle D, Accili D, McGraw TE (2011) Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci USA 108:10162–10167
Qi Y, Xu Z, Zhu Q, Thomas C, Kumar R, Feng H, Dostal DE, White MF, Baker KM, Guo S (2013) Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38alpha MAPK during insulin resistance. Diabetes 62:3887–3900
Funding
This work was supported by grants from the National Science Center to Irena Audzeyenka (No. 2012/05/N/NZ5/00808 and DEC-2014/12/T/NZ5/00273).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Audzeyenka, I., Rogacka, D., Piwkowska, A. et al. Viability of primary cultured podocytes is associated with extracellular high glucose-dependent autophagy downregulation. Mol Cell Biochem 430, 11–19 (2017). https://doi.org/10.1007/s11010-017-2949-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-017-2949-5